Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Nivestym
Nivestym Image


Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Nivestym?

Nivestym is a medication that belongs to the class of drugs known as Granulocyte Colony-Stimulating Factors (G-CSF). It is produced by Pfizer U.S. and is used to stimulate the production of white blood cells, specifically neutrophils, in patients who are undergoing certain cancer treatments. Neutrophils are a type of white blood cell that plays a crucial role in the body's immune response. Nivestym is typically prescribed to reduce the risk of infection in patients receiving chemotherapy that may weaken their immune system. This medication works by stimulating the bone marrow to produce more neutrophils, which helps to boost the body's ability to fight off infections. It's important to note that Nivestym is a prescription medication and should be used only under the guidance of a healthcare professional. Like any medication, it may have potential side effects, which can include bone pain, muscle aches, fever, and shortness of breath. It is essential to discuss any concerns or possible interactions with other medications with your doctor before starting this treatment.

How to use Nivestym?

Nivestym is a medication belonging to the Granulocyte Colony-Stimulating Factors (G-CSF) class, which is used to stimulate the production of white blood cells in the body. This drug is manufactured by Pfizer U.S. and is typically prescribed to help prevent or treat conditions such as febrile neutropenia, a low white blood cell count, in patients undergoing chemotherapy. The specific administration instructions for Nivestym may vary depending on the individual's condition and the healthcare provider's guidance. It is typically administered as an injection under the skin or through a vein. The dosage and frequency will be determined by the prescribing doctor and will be based on factors such as the patient's weight, medical history, and the specific condition being treated. It's crucial to follow the doctor's instructions precisely when using Nivestym. It's recommended to consult a healthcare professional for comprehensive guidance on how to properly administer the medication, including the correct dosage, injection technique, and any necessary precautions or potential side effects.

Nivestym is a medication belonging to the Granulocyte Colony-Stimulating Factors (G-CSF) class, produced by Pfizer U.S. It is primarily used in the treatment of neutropenia, a condition characterized by a low level of neutrophils (a type of white blood cell) in the body. When using Nivestym, there are several important warnings to be aware of. First and foremost, this drug should not be used in individuals with a known hypersensitivity to filgrastim or any other component of the medication. Allergic reactions can occur, manifesting as rashes, difficulty breathing, and swelling. Another important warning is related to the potential for spleen rupture. Patients should be monitored for signs of left upper abdominal or shoulder pain, as this may be indicative of a spleen-related concern. If such symptoms occur, immediate medical attention should be sought. Additionally, treatment with Nivestym can cause an increased risk of acute respiratory distress syndrome (ARDS). Patients should be closely monitored for any respiratory symptoms, such as shortness of breath or difficulty breathing. It's important to acknowledge that this is a brief overview of the warnings associated with Nivestym. It is crucial to consult with a healthcare professional or refer to the medication's prescribing information for comprehensive information, as there may be additional warnings, precautions, and potential side effects that need to be considered.

Before taking Nivestym, it is important to be aware of certain warnings and precautions. Nivestym is a medication that belongs to the Granulocyte Colony-Stimulating Factors (G-CSF) class of drugs and is produced by Pfizer U.S. It is commonly used to help stimulate the production of white blood cells, specifically neutrophils, in people undergoing certain medical treatments. Here are some important considerations before taking Nivestym: 1. Allergic reactions: Inform your healthcare provider if you have a history of allergies, particularly to any medications or similar drugs, as Nivestym may cause allergic reactions. 2. Infection risk: Nivestym increases the production of white blood cells, which can enhance the body's ability to fight infections. However, it is important to note that Nivestym does not prevent all types of infections. Be vigilant for signs of infection and promptly seek medical attention if any occur. 3. Leukemia or myelodysplastic syndrome: Individuals with certain types of leukemia or myelodysplastic syndrome (MDS) may have an increased risk of developing certain serious side effects when taking Nivestym. It's crucial to discuss your medical history with your healthcare provider before starting Nivestym. 4. Spleen-related complications: Nivestym may cause enlargement of the spleen or lead to rupture of the spleen. Inform your doctor if you have any history of spleen problems or if you experience abdominal pain or discomfort while taking Nivestym. 5. Lung-related complications: Rare cases of lung problems, including Acute Respiratory Distress Syndrome (ARDS), have been reported in individuals receiving Nivestym. Seek immediate medical attention if you experience difficulty breathing or any other respiratory symptoms. 6. Use during pregnancy and breastfeeding: The use of Nivestym during pregnancy or breastfeeding should be discussed with your healthcare provider to assess potential risks and benefits. It is important to follow your healthcare provider's instructions and report any concerning symptoms or side effects while taking Nivestym. They will be able to provide you with the most accurate and personalized guidance based on your individual situation.

Nivestym is a medication that belongs to the Granulocyte Colony-Stimulating Factors (G-CSF) class of drugs. It is manufactured by Pfizer U.S. and is used to support the production of white blood cells in individuals undergoing cancer treatment or certain types of bone marrow transplants. Like any medication, Nivestym can cause side effects. The most common side effects reported with this drug include bone pain and pain in the arms or legs. Other potential side effects may include headaches, fatigue, dizziness, nausea, vomiting, diarrhea, and loss of appetite. In some cases, more serious side effects can occur, although they are less common. These may include allergic reactions such as rash, itching, swelling, or difficulty breathing. It is important to contact a healthcare provider immediately if any of these serious side effects occur. It is worth mentioning that this is not an exhaustive list of side effects, and there may be other potential side effects associated with Nivestym. It is always recommended to consult with a healthcare professional or read the medication's accompanying information leaflet for a comprehensive list of potential side effects.

The active ingredient in Nivestym is filgrastim. Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) that is produced through genetic engineering. It is identical to the natural G-CSF protein that is produced in the body and plays a role in the regulation and production of white blood cells, specifically neutrophils. Nivestym also contains other inactive ingredients, including lactose monohydrate, polysorbate 80, and sodium chloride. These inactive ingredients help with the formulation, stability, and delivery of the medication. It's important to note that Nivestym is a biosimilar to a reference product called Neupogen, which also contains filgrastim as the active ingredient. Biosimilars are highly similar to the reference product, meaning they have no clinically meaningful differences in terms of safety, potency, and efficacy. However, they may have minor differences in their inactive ingredients or manufacturing processes.

Nivestym, a medication classified as a Granulocyte Colony-Stimulating Factor (G-CSF), is crucial in stimulating the production of white blood cells in patients undergoing certain treatments, such as chemotherapy or stem cell transplantation. Proper storage and handling of Nivestym are essential to maintain its effectiveness. Nivestym should be stored in the refrigerator, between a temperature range of 36°F to 46°F (2°C to 8°C). It is important to protect the medication from light and keep it in its original packaging until it is ready to be used. Do not freeze Nivestym or expose it to extreme temperatures, as this may alter its potency. It is recommended to avoid storing the medication in the freezer compartment of a refrigerator or near any freezing elements. If you are traveling and need to transport Nivestym, it can be kept at room temperature for up to 4 weeks. However, it should be used as soon as possible once it has reached room temperature. Make sure to consult the product's package insert or your healthcare provider for any specific storage instructions provided by the manufacturer. Always check the expiration date before using Nivestym. If the medication has expired, it should be disposed of properly and not used. It's worth noting that proper storage and handling of medications, including Nivestym, are crucial to ensure their safety and effectiveness. If you have any concerns or questions about storage or handling, consulting your healthcare provider or pharmacist is advised.